ArticleJournal of hepatology2020
Erratum to: 'Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance' (J Hepatol 2019; 71(1): 14-24).
Sabrina J Merat et al.PubMed ↗Publisher ↗
No numbers read from the abstract.